MRCP
ELV icon

Maple Rock Capital Partners’s Elevance Health ELV Stock Holding History

Maple Rock Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.1M Buy
191,500
+129,500
+209% +$48M 1.45% 20
2026
Q1 		$18.2M Buy
+62,000
New +$20.4M 0.59% 41

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Maple Rock Capital Partners's ELV Position: Q2 2026 in Review

Maple Rock Capital Partners increased its Elevance Health (ELV) stake by 209% in Q2 2026, buying an estimated $48M and bringing the position to 191,500 shares worth $74.1M. The position accounts for 1.45% of the portfolio, ranked #20.

Maple Rock Capital Partners first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Maple Rock Capital Partners held 191,500 shares of Elevance Health worth $74.1M as of Q2 2026.
  • Maple Rock Capital Partners bought 129,500 Elevance Health shares in Q2 2026, an estimated $48M.
  • Elevance Health made up 1.45% of Maple Rock Capital Partners's portfolio in Q2 2026, its #20 holding.
  • Maple Rock Capital Partners first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Maple Rock Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.